Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens

Journal of Controlled Release

Volumn 208, Issue , 2015, Pages 121-129

  Fan, Yuchen ^a   Sahdev, Preety ^a   Ochyl, Lukasz J ^a   J Akerberg, Jonathan ^a   Moon, James J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Intranasal vaccine; Liposome; Nanoparticle; Subunit antigen; Yersinia pestis

Indexed keywords

ANTIBODIES; ANTIGENS; COMPLEXATION; ENERGY TRANSFER; FLUORESCENCE; IMMUNE SYSTEM; LIGHT SCATTERING; LIPOSOMES; MAMMALS; NANOPARTICLES; NANOSTRUCTURES; ORGANIC ACIDS; T-CELLS; VACCINES;

FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMORAL IMMUNE RESPONSE; HYBRID NANOPARTICLE; INFECTIOUS PATHOGENS; INTRANASAL; NANOPARTICLE TRACKING ANALYSIS; SHELL NANOSTRUCTURES; YERSINIA PESTIS;

HYALURONIC ACID;

ANTIGEN; CATION; COLLOID; HYALURONIC ACID; LIPID A; LIPOSOME; NANOPARTICLE; VACCINE;

ADAPTIVE IMMUNITY; ANIMAL; C57BL MOUSE; CHEMISTRY; COLLOID; DENDRITIC CELL; DRUG EFFECTS; HUMORAL IMMUNITY; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; MOUSE; PLAGUE; PROCEDURES; VACCINATION; YERSINIA PESTIS;

ADAPTIVE IMMUNITY; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS; CATIONS; COLLOIDS; DENDRITIC CELLS; HYALURONIC ACID; IMMUNITY, HUMORAL; LIPID A; LIPOSOMES; MICE; MICE, INBRED C57BL; NANOPARTICLES; PLAGUE; VACCINATION; VACCINES; YERSINIA PESTIS;

EID: 84936768744     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.04.010     Document Type: Article

References (45)

1. D.J. Irvine, M.A. Swartz, and G.L. Szeto Engineering synthetic vaccines using cues from natural immunity Nat. Mater. 12 2013 978 990
2. J.J. Moon, B. Huang, and D.J. Irvine Engineering nano- and microparticles to tune immunity Adv. Mater. 24 2012 3724 3746
3. P. Sahdev, L.J. Ochyl, and J.J. Moon Biomaterials for nanoparticle vaccine delivery systems Pharm. Res. 31 2014 2563 2582
4. G. Gregoriadis, R. Saffie, and J.B. de Souza Liposome-mediated DNA vaccination FEBS Lett. 402 1997 107 110
5. Y. Perrie, P.M. Frederik, and G. Gregoriadis Liposome-mediated DNA vaccination: the effect of vesicle composition Vaccine 19 2001 3301 3310
6. W. Yan, W. Chen, and L. Huang Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine J. Control. Release 130 2008 22 28
7. W. Chen, W. Yan, and L. Huang A simple but effective cancer vaccine consisting of an antigen and a cationic lipid Cancer Immunol. Immunother. 57 2008 517 530
8. D. Christensen, K.S. Korsholm, P. Andersen, and E.M. Agger Cationic liposomes as vaccine adjuvants Expert Rev. Vaccines 10 2011 513 521
9. K. Lappalainen, I. Jaaskelainen, K. Syrjanen, A. Urtti, and S. Syrjanen Comparison of cell proliferation and toxicity assays using two cationic liposomes Pharm. Res. 11 1994 1127 1131
10. H. Lv, S. Zhang, B. Wang, S. Cui, and J. Yan Toxicity of cationic lipids and cationic polymers in gene delivery J. Control. Release 114 2006 100 109
11. J.J. Moon, H. Suh, A. Bershteyn, M.T. Stephan, H. Liu, B. Huang, M. Sohail, S. Luo, S.H. Um, H. Khant, J.T. Goodwin, J. Ramos, W. Chiu, and D.J. Irvine Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses Nat. Mater. 10 2011 243 251
12. P.C. DeMuth, J.J. Moon, H. Suh, P.T. Hammond, and D.J. Irvine Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery ACS Nano 6 2012 8041 8051
13. A.V. Li, J.J. Moon, W. Abraham, H. Suh, J. Elkhader, M.A. Seidman, M. Yen, E.J. Im, M.H. Foley, D.H. Barouch, and D.J. Irvine Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination Sci. Transl. Med. 5 2013 204ra130
14. A.A. Gasperini, X.E. Puentes-Martinez, T.A. Balbino, T. de Paula Rigoletto, G. de Sa Cavalcanti Correa, A. Cassago, R.V. Portugal, L.G. de La Torre, and L.P. Cavalcanti Association between cationic liposomes and low molecular weight hyaluronic acid Langmuir 31 2015 3308 3317
15. M. Singh, M. Briones, and D.T. O'Hagan A novel bioadhesive intranasal delivery system for inactivated influenza vaccines J. Control. Release 70 2001 267 276
16. R.J. Verheul, B. Slutter, S.M. Bal, J.A. Bouwstra, W. Jiskoot, and W.E. Hennink Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination J. Control. Release 156 2011 46 52
17. R.J. Verheul, S. van der Wal, and W.E. Hennink Tailorable thiolated trimethyl chitosans for covalently stabilized nanoparticles Biomacromolecules 11 2010 1965 1971
18. L.E. Quenee, N.A. Ciletti, D. Elli, T.M. Hermanas, and O. Schneewind Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines Vaccine 29 2011 6572 6583
19. N. Csaba, M. Garcia-Fuentes, and M.J. Alonso Nanoparticles for nasal vaccination Adv. Drug Deliv. Rev. 61 2009 140 157
20. D.G. Heath, G.W. Anderson Jr., J.M. Mauro, S.L. Welkos, G.P. Andrews, J. Adamovicz, and A.M. Friedlander Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine Vaccine 16 1998 1131 1137
21. S. Uddowla, L.C. Freytag, and J.D. Clements Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens Vaccine 25 2007 7984 7993
22. K.A. Ross, S.L. Haughney, L.K. Petersen, P. Boggiatto, M.J. Wannemuehler, and B. Narasimhan Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours Adv. Healthc. Mater. 3 2014 1071 1077
23. B.D. Ulery, D. Kumar, A.E. Ramer-Tait, D.W. Metzger, M.J. Wannemuehler, and B. Narasimhan Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases PLoS One 6 2011 e17642
24. B. Guy The perfect mix: recent progress in adjuvant research Nat. Rev. Microbiol. 5 2007 505 517
25. C.R. Alving, M. Rao, N.J. Steers, G.R. Matyas, and A.V. Mayorov Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines Expert Rev. Vaccines 11 2012 733 744
26. V. Filipe, A. Hawe, and W. Jiskoot Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates Pharm. Res. 27 2010 796 810
27. G.E. Sims, and T.J. Snape A method for the estimation of polyethylene glycol in plasma protein fractions Anal. Biochem. 107 1980 60 63
28. X.W. Gong, D.Z. Wei, M.L. He, and Y.C. Xiong Discarded free PEG-based assay for obtaining the modification extent of pegylated proteins Talanta 71 2007 381 384
29. D. Hoekstra Role of lipid phase separations and membrane hydration in phospholipid vesicle fusion Biochemistry 21 1982 2833 2840
30. S. Osanai, and K. Nakamura Effects of complexation between liposome and poly(malic acid) on aggregation and leakage behaviour Biomaterials 21 2000 867 876
31. C. Berney, and G. Danuser FRET or no FRET: a quantitative comparison Biophys. J. 84 2003 3992 4010
32. M.B. Lutz, N. Kukutsch, A.L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow J. Immunol. Methods 223 1999 77 92
33. M. Ishiyama, Y. Miyazono, K. Sasamoto, Y. Ohkura, and K. Ueno A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability Talanta 44 1997 1299 1305
34. + T cell responses after nanoparticle vaccination J. Vis. Exp. 2015 e52771 10.3791/52771
35. J. Banchereau, and A.K. Palucka Dendritic cells as therapeutic vaccines against cancer Nat. Rev. Immunol. 5 2005 296 306
36. D.C. Miller, and G.P. Dahl Early events in calcium-induced liposome fusion Biochim. Biophys. Acta 689 1982 165 169
37. D. Papahadjopoulos, S. Nir, and N. Duzgunes Molecular mechanisms of calcium-induced membrane fusion J. Bioenerg. Biomembr. 22 1990 157 179
38. Y. Xia, J. Sun, and D. Liang Aggregation, fusion, and leakage of liposomes induced by peptides Langmuir 30 2014 7334 7342
39. K. Arnold, S. Ohki, and M. Krumbiegel Interaction of dextran sulfate with phospholipid surfaces and liposome aggregation and fusion Chem. Phys. Lipids 55 1990 301 307
40. A.A. Yaroslavov, A.V. Sybachin, E. Kesselman, J. Schmidt, Y. Talmon, S.A. Rizvi, and F.M. Menger Liposome fusion rates depend upon the conformation of polycation catalysts J. Am. Chem. Soc. 133 2011 2881 2883
41. B. Slutter, S. Bal, C. Keijzer, R. Mallants, N. Hagenaars, I. Que, E. Kaijzel, W. van Eden, P. Augustijns, C. Lowik, J. Bouwstra, F. Broere, and W. Jiskoot Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen Vaccine 28 2010 6282 6291
42. T. Uto, X. Wang, T. Akagi, R. Zenkyu, M. Akashi, and M. Baba Improvement of adaptive immunity by antigen-carrying biodegradable nanoparticles Biochem. Biophys. Res. Commun. 379 2009 600 604
43. A. Glynn, L.C. Freytag, and J.D. Clements Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens Vaccine 23 2005 1957 1965
44. T. Jones, J.J. Adamovicz, S.L. Cyr, C.R. Bolt, N. Bellerose, L.M. Pitt, G.H. Lowell, and D.S. Burt Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection Vaccine 24 2006 1625 1632
45. A. Glynn, C.J. Roy, B.S. Powell, J.J. Adamovicz, L.C. Freytag, and J.D. Clements Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens Infect. Immun. 73 2005 5256 5261